ADVANCING PATIENT CARE
Globally, Benign Prostatic Hyperplasia (BPH) is one of the most common diseases among aging men , affecting one in every two men over the age of 50 and virtually every male over 80 years of age, comprising over 85 million men worldwide.
The Pathfinder Laser Solution advances patient care and the availability of laser BPH treatments with a portable, cost-effective medical laser and fiber for hospitals, surgical centers, and with its unique value proposition, paves the way for in-office BPH laser treatments for private practice urologists.
 American Urological Association. Diagnosis and treatment recommendation. In: AUA Guidelines on the Management of Benign Prostatic Hyperplasia: Litnthicum, MD: American Urological Association Education and Research, Inc.: 2003; 4:1-43.